Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis (original) (raw)
Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic Mice
Thomas Wisniewski
The American Journal of Pathology, 2001
View PDFchevron_right
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
Dag Sehlin
Neurobiology of Disease, 2009
View PDFchevron_right
Novel Aβ peptide immunogens modulate plaque pathology and inflammation in a murine model of Alzheimer's disease
Maria Isabel Burgos Fonseca
2005
View PDFchevron_right
Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology
Catherine Canon
Proceedings of the National Academy of Sciences, 2003
View PDFchevron_right
The generation and characterization of potentially therapeutic Aβ antibodies in mice: differences according to strain and immunization protocol
Cynthia Lemere
Vaccine, 2002
View PDFchevron_right
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
kim weiss
Nature Medicine, 2000
View PDFchevron_right
Amelioration of amyloid load by anti-Aβ single-chain antibody in Alzheimer mouse model
Ken-ichiro Fukuchi
Biochemical and Biophysical Research Communications, 2006
View PDFchevron_right
Epitope and isotype specificities of antibodies to -amyloid peptide for protection against Alzheimer's disease-like neuropathology
minh nguyen
Proceedings of The National Academy of Sciences, 2003
View PDFchevron_right
An Attenuated Immune Response Is Sufficient to Enhance Cognition in an Alzheimer's Disease Mouse Model Immunized with Amyloid-β Derivatives
Thomas Wisniewski
The Journal of Neuroscience, 2004
View PDFchevron_right
Reduced effectiveness of Aβ1-42 immunization in APP transgenic mice with significant amyloid deposition
pritam das
Neurobiology of Aging, 2001
View PDFchevron_right
Aβ42 gene vaccination reduces brain amyloid plaque burden in transgenic mice
Linda S Hynan
Journal of the Neurological Sciences, 2006
View PDFchevron_right
Experimental Investigation of Antibody-Mediated Clearance Mechanisms of Amyloid-β in CNS of Tg-SwDI Transgenic Mice
M. Previti
The Journal of Neuroscience, 2007
View PDFchevron_right
Amyloid-β Immunotherapy on Alzheimer disease: Prevention and Therapeutic Target
Opeyemi Adeloye
Journal of dermatology research and review, 2020
View PDFchevron_right
Immunotherapy Targeting Amyloid-β Peptides in Alzheimer’s Disease
Silvia Zampar
Alzheimer’s Disease: Drug Discovery, 2020
View PDFchevron_right
Amyloid-β immunisation for Alzheimer's disease
Thomas Wisniewski
The Lancet Neurology, 2008
View PDFchevron_right
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
JC Dodart
Proceedings of the National Academy of Sciences, 2001
View PDFchevron_right
MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice
Cynthia Lemere
The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013
View PDFchevron_right
Immunotherapy for Alzheimer's disease: attacking amyloid-β from the inside
Beka Solomon
Trends in Immunology, 2007
View PDFchevron_right
Monoclonal antibodies that target pathological assemblies of Aβ
Sara Dunne, Kirsten Viola, Grant Krafft
Journal of Neurochemistry, 2007
View PDFchevron_right
Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease
Sandra Villegas
mAbs, 2013
View PDFchevron_right
Immunological Approach for the Treatment of Alzheimer's Disease
Beka Solomon
Journal of Molecular Neuroscience, 2003
View PDFchevron_right
Immunotherapy for Alzheimer's disease: attacking amyloid-â from the inside
Beka Solomon
Trends in Immunology, 2007
View PDFchevron_right